Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy

Stefanie Krassnig; Stefan L Leber; Andrea Orthmann; Nicole Golob-Schwarzl; Heinrich Johann Huber; Christina Wohlrab; Christina Skofler; Mirjam Pennauer; Andrea Raicht; Anna Maria Birkl-Toeglhofer; M. Naumann; Karlem Mahdy-Ali; Gord von Campe; Marlene Leoni; Joshua Alcaniz; Jens Hoffmann; Thomas Wälchli; Serge Weis; Martin Benesch; Johanes Haybaeck

doi:10.1007/s11060-023-04451-y

Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy

Stefanie Krassnig
, Stefan L Leber
, Andrea Orthmann
, Nicole Golob-Schwarzl
, Heinrich Johann Huber
, Christina Wohlrab
, Christina Skofler
, Mirjam Pennauer
, Andrea Raicht
, Anna Maria Birkl-Toeglhofer
, M. Naumann
, Karlem Mahdy-Ali
, Gord von Campe
, Marlene Leoni
, Joshua Alcaniz
, Jens Hoffmann
, Thomas Wälchli
, Serge Weis
, Martin Benesch
, Johanes Haybaeck

Department of Pathology and Molecular Pathology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	91-100
Number of pages	10
Journal	Journal of Neuro-Oncology
Volume	165
Issue number	1
DOIs	https://doi.org/10.1007/s11060-023-04451-y
Publication status	Published - Oct 2023

Fields of science

301101 General pathology
301108 Molecular pathology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s11060-023-04451-y

Cite this

Krassnig, S., Leber, S. L., Orthmann, A., Golob-Schwarzl, N., Huber, H. J., Wohlrab, C., Skofler, C., Pennauer, M., Raicht, A., Birkl-Toeglhofer, A. M., Naumann, M., Mahdy-Ali, K., von Campe, G., Leoni, M., Alcaniz, J., Hoffmann, J., Wälchli, T., Weis, S., Benesch, M., & Haybaeck, J. (2023). Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy. Journal of Neuro-Oncology, 165(1), 91-100. https://doi.org/10.1007/s11060-023-04451-y

@article{3264ec925659422d95406a8746f14a53,

title = "Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy",

author = "Stefanie Krassnig and Leber, \{Stefan L\} and Andrea Orthmann and Nicole Golob-Schwarzl and Huber, \{Heinrich Johann\} and Christina Wohlrab and Christina Skofler and Mirjam Pennauer and Andrea Raicht and Birkl-Toeglhofer, \{Anna Maria\} and M. Naumann and Karlem Mahdy-Ali and \{von Campe\}, Gord and Marlene Leoni and Joshua Alcaniz and Jens Hoffmann and Thomas W{\"a}lchli and Serge Weis and Martin Benesch and Johanes Haybaeck",

year = "2023",

month = oct,

doi = "10.1007/s11060-023-04451-y",

language = "English",

volume = "165",

pages = "91--100",

journal = "Journal of Neuro-Oncology",

issn = "1573-7373",

number = "1",

}

Krassnig, S, Leber, SL, Orthmann, A, Golob-Schwarzl, N, Huber, HJ, Wohlrab, C, Skofler, C, Pennauer, M, Raicht, A, Birkl-Toeglhofer, AM, Naumann, M, Mahdy-Ali, K, von Campe, G, Leoni, M, Alcaniz, J, Hoffmann, J, Wälchli, T, Weis, S, Benesch, M & Haybaeck, J 2023, 'Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy', Journal of Neuro-Oncology, vol. 165, no. 1, pp. 91-100. https://doi.org/10.1007/s11060-023-04451-y

TY - JOUR

T1 - Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy

AU - Krassnig, Stefanie

AU - Leber, Stefan L

AU - Orthmann, Andrea

AU - Golob-Schwarzl, Nicole

AU - Huber, Heinrich Johann

AU - Wohlrab, Christina

AU - Skofler, Christina

AU - Pennauer, Mirjam

AU - Raicht, Andrea

AU - Birkl-Toeglhofer, Anna Maria

AU - Naumann, M.

AU - Mahdy-Ali, Karlem

AU - von Campe, Gord

AU - Leoni, Marlene

AU - Alcaniz, Joshua

AU - Hoffmann, Jens

AU - Wälchli, Thomas

AU - Weis, Serge

AU - Benesch, Martin

AU - Haybaeck, Johanes

PY - 2023/10

Y1 - 2023/10

UR - https://www.scopus.com/pages/publications/85175328537

U2 - 10.1007/s11060-023-04451-y

DO - 10.1007/s11060-023-04451-y

M3 - Article

C2 - 37907716

SN - 1573-7373

VL - 165

SP - 91

EP - 100

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

IS - 1

ER -

Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this